---
date: 2021-11-23
title: "Journée annuelle du GT Bioss (2021, 6e édition)"
summary: "Le **mardi 23 novembre 2021** à **Lyon** à l'Université Claude Bernard (Campus de la Doua, Lyon), juste avant la journée nationale du GDR BiM"
categories: "Manifestations"
---

## Informations générales

**Date** : le 23 novembre 2021 de 9h30 à 17h30

**Lieu** : Université Claude Bernard, Campus de la Doua, Lyon.

**Organisateurs** : Russ Harmer, Laurence Calzone, Cédric Lhoussaine, Loïc Paulevé et Élisabeth Remy


Cette sixième édition des journées annuelles du GT Bioss se déroulera juste avant la journée nationale du [GDR BiM](http://www.gdr-bim.cnrs.fr) qui aura lieu le 24 novembre à l'Université Claude Bernard.


## Inscription

L'inscription, gratuite mais obligatoire, se fait via la [page du GDR BiM de l'évènement](https://www.gdr-bim.cnrs.fr/journees-du-gdr-bim-2021).

## Programme

La journée se déroulera entre 9h et 17h.

Envoyez vos propositions d'exposé à [contact@bioss-cnrs.fr](mailto:contact@bioss-cnrs.fr).

Orateurs invités:
* **[Alberto Valdeolivas](https://scholar.google.fr/citations?user=9gqm7GYAAAAJ)** (Roche Pharma Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, Basel, Switzerland)
* **[Delphine Ropers](https://team.inria.fr/ibis/delphine-ropers/)** (Inria Grenoble – Rhône-Alpes)
* **Thomas Guillemaud** et **Celine Scornavacca** ([Peer Community In - PCI](https://mcb.peercommunityin.org/))


### Résumés

**Alberto Valdeolivas** - *Exploring colorectal cancer heterogeneity with Spatial Transcriptomics*.\
Colorectal cancer (CRC) is a leading cause of cancer-related death worldwide with over 1.85 million diagnosed cases and 850 000 deaths annually. CRC mortality rates have improved in recent years as a result of treatments tailored to the molecular and pathological features of the different groups of patients. The  integrative analysis of large scale DNA and RNA sequencing data profoundly contributed to characterize CRC diversity and resulted in the classification of CRC into four consensus molecular subtypes (CMS) with distinguishing features. However, the spatial heterogeneity of CMS subtypes and its potential relevance for treatment decisions remains elusive.\
In the last decade, we have witnessed substantial advances in next generation sequencing and multiplex bioimaging based technologies. The effective combination of these approaches paved the development of Spatial Transcriptomics (ST). ST enables measuring of gene expression levels throughout sample space, preserving the cellular distribution in the tissue under analysis. These expression maps are crucial for understanding the influence of cellular and tissue organization in their biological function, and can therefore lead to new insights in a large variety of areas, such as disease understanding.\
In this study, we applied ST and a deconvolution-based approach to decipher the CMS and spatial heterogeneity of seven CRC samples. We further used our ST data to investigate cell communication at the tumor stroma interface. Our results suggest large variability among CMS2 tumors at the gene expression, pathway and transcription factor activity levels. In addition, we found substantial differences in the molecular features of their surrounding stroma.
